Esco Group President and CEO
XQ is the President and CEO of Esco Group. As a life sciences entrepreneur with track records in developing and scaling up businesses from concepts, XQ has extensive global operational experience. Through various positions from 1997 to 2011, XQ re-engineered Esco from a cleanroom business into a biotechnology business and launched a range of life sciences laboratory tools, including Esco’s world leading biosafety cabinet product line. He was pivotal in transforming Esco from a regional business into a global life sciences equipment provider, growing shareholder value of 25%+ CAGR over 15 years. In 2012, XQ further expanded the life sciences laboratory tools portfolio by establishing Esco Medical to provide world class and innovative solutions in in-vitro fertilization and assisted reproductive technology.
XQ is also the Founder and Managing Partner of Esco Ventures, the life sciences investment arm of Esco Group. Focusing on early stage investments in life sciences tools & diagnostics, women’s health and reproductive medicine of unmet medical needs, XQ has invested in more than 10 life sciences start-ups with a total portfolio IRR of approximately 45% to date.
To further complement the Esco Group Life Sciences ecosystem, XQ launched Esco Ventures X to embark on innovative biotech venture creation focused on platform technologies. Today, XQ is the Co-Founder and Chairman of Carmentix Pte Ltd, the inaugural venture creation of Esco Ventures X, which is developing a novel prognostic test to predict the risk of preterm birth in asymptomatic women. In parallel, XQ is also incubating multiple venture creations under stealth mode, with a current focus on biotech/therapeutics platforms. To further enhance the venture creation portfolio, XQ has started the Esco Ventures Fellowship Programme to groom the next generation of life sciences entrepreneurs.
XQ graduated from the Wharton School of Business at the University of Pennsylvania with a BS in Economics and Finance in 2009.